UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

Cell cycle (Georgetown, Tex.), 2009-03, Vol.8 (6), p.909-915

2009

Volltextzugriff (PDF)

Metformin induces unique biological and molecular responses in triple negative breast cancer cells

Cell cycle (Georgetown, Tex.), 2009-07, Vol.8 (13), p.2031-2040

2009

Volltextzugriff (PDF)

MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence

PloS one, 2010-06, Vol.5 (6), p.e10748

2010

Volltextzugriff (PDF)

Inhibition of MYC attenuates tumor cell self‐renewal and promotes senescence in SMARCB1‐deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo

International journal of cancer, 2019-04, Vol.144 (8), p.1983-1995

2019

Volltextzugriff (PDF)

MicroRNA 218 Acts as a Tumor Suppressor by Targeting Multiple Cancer Phenotype-associated Genes in Medulloblastoma

The Journal of biological chemistry, 2013-01, Vol.288 (3), p.1918-1928

2013

Volltextzugriff (PDF)

Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells

Neuro-oncology (Charlottesville, Va.), 2013-02, Vol.15 (2), p.149-160

2013

Volltextzugriff (PDF)

Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG

Cell reports (Cambridge), 2020-10, Vol.33 (3), p.108286-108286, Article 108286

2020

Volltextzugriff (PDF)

Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells

BMC cancer, 2012-03, Vol.12 (1), p.80-80, Article 80

2012

Volltextzugriff (PDF)

Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma

Oncotarget, 2014-05, Vol.5 (9), p.2355-2371

2014

Volltextzugriff (PDF)

Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma

Molecular cancer, 2014-03, Vol.13 (1), p.72-72, Article 72

2014

Volltextzugriff (PDF)

MPS1 kinase as a potential therapeutic target in medulloblastoma

Oncology reports, 2016-11, Vol.36 (5), p.2633-2640

2016

Volltextzugriff (PDF)

Loss of CAK phosphorylation of RARα mediates transcriptional control of retinoid-induced cancer cell differentiation

The FASEB journal, 2010-03, Vol.24 (3), p.833-843

2010

Volltextzugriff (PDF)

Peculiarities of night EEG-monitoring of sleep in children with type 1 diabetes mellitus depending on the glycemia level

Sakharnyĭ diabet, 2018-08, Vol.21 (3), p.186-192

2018

Volltextzugriff (PDF)

Diabetes mellitus type 1 in childhood

Sakharnyĭ diabet, 2020-06, Vol.23 (1S), p.4-40

2020

Volltextzugriff (PDF)

ATRT-01. PARP INHIBITION AS A THERAPEUTIC TARGET IN ATRT

Neuro-oncology (Charlottesville, Va.), 2023-06, Vol.25 (Supplement_1), p.i1-i1

2023

Volltextzugriff (PDF)

The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER‐2/neu transgenic mice

International journal of cancer, 2003-01, Vol.103 (3), p.300-305

2003

Volltextzugriff (PDF)

ATRT-07. PRC1/BMI1 ACTIVITY ALTERS CHROMATIN ACCESSIBILITY TO REGULATE DIFFERENTIATION IN ATYPICAL TERATOID RHABDOID TUMORS

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

EPEN-23. TARGETING TRISOMY MDM4 INDUCES CELL DEATH IN 1Q+ PFA EPENDYMOMA THROUGH REACTIVATION OF THE P53 PATHWAY

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

Rodent models for the preclinical evaluation of drugs suitable for pharmacological intervention in aging

Expert opinion on drug discovery, 2012-01, Vol.7 (1), p.85-95

2012

Volltextzugriff (PDF)

ATRT-08. TARGETING THE TP53-MDM2 ENHANCES RADIATION SENSITIVITY IN ATRT

Neuro-oncology (Charlottesville, Va.), 2021-06, Vol.23 (Supplement_1), p.i2-i3

2021

Volltextzugriff (PDF)

DIPG-55. TARGETING SENESCENT CELLS WITH ABT-263 ENHANCES CELL DEATH INDUCED BY BMI1 INHIBITION AND IONIZING RADIATION IN DIPG

Neuro-oncology (Charlottesville, Va.), 2018-06, Vol.20 (suppl_2), p.i60-i60

2018

Volltextzugriff (PDF)

A novel PLK1 inhibitor onvansertib effectively sensitizes MYC-driven medulloblastoma to radiotherapy

Neuro-oncology (Charlottesville, Va.), 2022-03, Vol.24 (3), p.414-426

2022

Volltextzugriff (PDF)

Dose-dependent effect of melatonin on life span and spontaneous tumor incidence in female SHR mice

Experimental gerontology, 2003-04, Vol.38 (4), p.449-461

2003

Volltextzugriff (PDF)

Clinical characteristics of gastroesophageal reflux disease in adolescents with diabetic cardiac autonomic neuropathy

Sakharnyĭ diabet, 2014-01, Vol.17 (4), p.93-98

2014

Volltextzugriff (PDF)

ATRT-23. SIRT2 cooperates with SMARCB1 to induce a differentiation block in ATRT

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i8-i8

2022

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(77)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

Metformin induces unique biological and molecular responses in triple negative breast cancer cells

MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence

Inhibition of MYC attenuates tumor cell self‐renewal and promotes senescence in SMARCB1‐deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo

MicroRNA 218 Acts as a Tumor Suppressor by Targeting Multiple Cancer Phenotype-associated Genes in Medulloblastoma

Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells

Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG

Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells

Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma

Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma

MPS1 kinase as a potential therapeutic target in medulloblastoma

Loss of CAK phosphorylation of RARα mediates transcriptional control of retinoid-induced cancer cell differentiation

Peculiarities of night EEG-monitoring of sleep in children with type 1 diabetes mellitus depending on the glycemia level

Diabetes mellitus type 1 in childhood

ATRT-01. PARP INHIBITION AS A THERAPEUTIC TARGET IN ATRT

The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER‐2/neu transgenic mice

ATRT-07. PRC1/BMI1 ACTIVITY ALTERS CHROMATIN ACCESSIBILITY TO REGULATE DIFFERENTIATION IN ATYPICAL TERATOID RHABDOID TUMORS

EPEN-23. TARGETING TRISOMY MDM4 INDUCES CELL DEATH IN 1Q+ PFA EPENDYMOMA THROUGH REACTIVATION OF THE P53 PATHWAY

Rodent models for the preclinical evaluation of drugs suitable for pharmacological intervention in aging

ATRT-08. TARGETING THE TP53-MDM2 ENHANCES RADIATION SENSITIVITY IN ATRT

DIPG-55. TARGETING SENESCENT CELLS WITH ABT-263 ENHANCES CELL DEATH INDUCED BY BMI1 INHIBITION AND IONIZING RADIATION IN DIPG

A novel PLK1 inhibitor onvansertib effectively sensitizes MYC-driven medulloblastoma to radiotherapy

Dose-dependent effect of melatonin on life span and spontaneous tumor incidence in female SHR mice

Clinical characteristics of gastroesophageal reflux disease in adolescents with diabetic cardiac autonomic neuropathy

ATRT-23. SIRT2 cooperates with SMARCB1 to induce a differentiation block in ATRT

Suchergebnisse filtern